GIPC, or gliclazide, is a second-generation sulfonylurea antidiabetic agent primarily used to manage blood glucose levels in patients with type 2 diabetes by stimulating insulin secretion from pancreatic… Read more
GIPC, or gliclazide, is a second-generation sulfonylurea antidiabetic agent primarily used to manage blood glucose levels in patients with type 2 diabetes by stimulating insulin secretion from pancreatic beta cells. In pharmaceutical analysis, identifying and quantifying related compounds is critical for ensuring the safety and efficacy of therapeutic formulations. This category provides high-quality reference standards, including identified impurities and degradation products, which are essential for rigorous impurity profiling and method validation. Laboratories rely on these analytical standards to develop reliable testing procedures, ensuring that drug products meet strict pharmacopoeial specifications. Additionally, stable isotope labelled compounds are available to serve as internal standards for mass spectrometry-based assays, facilitating the accurate detection of trace contaminants during stability testing and routine quality control. Utilizing these specialized reference materials supports the maintenance of consistent manufacturing standards and the overall integrity of gliclazide pharmaceutical products.